SPOT ON
Switching from other NOACs to rivaroxaban generics?
NEW ON THE MARKET
Rimegepant (VYDURA) for preventive treatment of migraine
THERAPY FROM A CRITICAL VIEWPOINT
High-dose influenza vaccine EFLUELDA: new data
Once again: beta-blockers after myocardial infarction without reduced ejection fraction?
Anticoagulation after ablation of atrial fibrillation
IN BRIEF
Hyaluronic acid against knee or hip osteoarthritis?
Carpal tunnel syndrome: surgery or injection?
Protection of minors fails: e-cigarettes are gateway drugs
a-t READERS QUESTIONS AND COMMENTS
On the risk of anaphylaxis with parenteral iron
SIDE EFFECTS
Agranucytosis with clozapine: new instructions for blood count monitoring
Liver damage due to cannabidiol (CBD)
Yet again: ashwagandha and liver damage free article
e a-t ON THE INTERNET
Once again: beta-blockers after myocardial infarction without reduced ejection fraction? (long version)